Swiss National Bank’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Swiss National Bank’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-62,400	Closed	-$2.9M	–	2638
2023 Q2	$2.9M	Sell	62,400 -4,500	-7%	-$156K	﹤0.01%	1648
2023 Q1	$1.92M	Sell	66,900 -5,900	-8%	-$175K	﹤0.01%	1864
2022 Q4	$2.27M	Buy	72,800 +50,300	+224%	+$1.64M	﹤0.01%	1816
2022 Q3	$456K	Hold	22,500	–	–	﹤0.01%	2601
2022 Q2	$349K	Buy	+22,500	New	+$387K	﹤0.01%	2691

Swiss National Bank's DICE Position: Q3 2023 in Review

Swiss National Bank sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 62,400 shares — an estimated $2.9M sold.

Swiss National Bank first reported a position in DICE in Q2 2022 and held it in 5 quarters. The position peaked at $2.9M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Swiss National Bank reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Swiss National Bank sold 62,400 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.9M.
Swiss National Bank first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Swiss National Bank's DICE Therapeutics, Inc. Common Stock position peaked at $2.9M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Swiss National Bank's 13F filing for Q3 2023, filed 8 Nov 2023.